The DOI matches its Crossref record; 135 of the 137 references it cites were found in a registry or an index.
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
Open accessAbstract
Hepatic cirrhosis and hepatocellular carcinoma (HCC) are the most common causes of death in patients with chronic liver disease. Chronic liver injury of virtually any etiology triggers inflammatory and wound-healing responses that in the long run promote the development of hepatic fibrosis and HCC. Here, we review the role of the transcription factor nuclear factor-κB (NF-κB), a master regulator of inflammation and cell death, in the development of hepatocellular injury, liver fibrosis and HCC, with a particular focus on the role of NF-κB in different cellular compartments of the liver. We propose that NF-κB acts as a central link between hepatic injury, fibrosis and HCC, and that it may represent a target for the prevention or treatment of liver fibrosis and HCC. However, NF-κB acts as a two-edged sword and inhibition of NF-κB may not only exert beneficial effects but also negatively impact hepatocyte viability, especially when NF-κB inhibition is pronounced. Finding appropriate targets or identifying drugs that either exert only a moderate effect on NF-κB activity or that can be specifically delivered to nonparenchymal cells will be essential to avoid the increase in liver injury associated with complete NF-κB blockade in hepatocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the decisive factor is that NF-κB-activation additionally causes a significantly increased resistance against apoptosis in aHSCs.[21]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Activators and Target Genes of Rel/NF-кB Transcription Factors
Loop, T., & Pahl, H. L. (2003) · Springer eBooks · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,179
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
Cited by
Sorted by citations
Items 801–900 of 999
Xu, X., Feng, J., Wang, X., Zeng, X., Luo, Y., He, X., Yang, M., Lv, T., Feng, Z., Bao, L., et al. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00562 · Cited by 12
Mechanism of PANoptosis in metabolic dysfunction-associated steatotic liver disease
Ni, K., & Meng, L. (2024) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2024.102381 · Cited by 14
Sánchez‐López, C. M., González, A., Ramírez‐Toledo, V., Bernal, D., & Marcilla, A. (2024) · International Journal for Parasitology · doi:10.1016/j.ijpara.2024.06.002 · Cited by 12
Salvianolic acid B in fibrosis treatment: a comprehensive review
Liang, Q., Liu, X., Peng, X., Luo, T., Su, Y. R., Xu, X., Xie, H., Gao, H. C., Chen, Z., & Xie, C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1442181 · Cited by 13
Zhang, X., & Nguyen, M. H. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156190 · Cited by 15
Transmembrane protein 106C promotes the development of hepatocellular carcinoma
Luo, X., Han, G., Lu, R., Guan, S., Wang, Y., Ju, L., Chen, L., Shao, J., & Bian, Z. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29678 · Cited by 12
Chen, K., Qu, J., Chen, H., Wang, J., Hua, H., Li, J., Zhou, L., Zhang, W., & Li, Z. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153685 · Cited by 12
Su, S.-B., Lin, T., Liang, X., & Chen, W. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.11.002 · Cited by 13
Qiu, J., Chai, Y.-N., Duan, F.-Y., Zhang, H., Han, X.-Y., Chen, L., & Duan, F. (2022) · Acta Biochimica Polonica · doi:10.18388/abp.2020_5802 · Cited by 13
Ahluwalia, S., Ahmad, B., Salim, U., Ghosh, D., Kamuju, V., Ghosh, A., Dabeer, K., Menon, M. B., & Vivekanandan, P. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02731-21 · Cited by 12
Nokkeaw, A., Thamjamrassri, P., Tangkijvanich, P., & Ariyachet, C. (2023) · Cells · doi:10.3390/cells12030378 · Cited by 13
Xinyu, W., Qian, W., Wu, Y., Kong, J., Keying, X., Jiao, J., Zhang, H., Wang, K., Xu, X., & Zhan, L. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06170-8 · Cited by 13
Thomas, N. S., George, K., & Nalini, N. (2015) · Hepatology Research · doi:10.1111/hepr.12569 · Cited by 12
Docetaxel-carboxymethylcellulose nanoparticles ameliorate CCl4-induced hepatic fibrosis in mice
Chang, C.-C., Yang, Y., Gao, D.-Y., Cheng, H., Hoang, B., Chao, P., Chen, L.-H., Bteich, J., Chiang, T., Liu, J., et al. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1419358 · Cited by 12
IL-6-Driven FasL Promotes Nf-κBp65/PUMA-Mediated Apoptosis in Portal Hypertensive Gastropathy
Tan, S., Xu, M., Ke, B., Lu, Y., Liu, H., Jiang, J., & Wu, B. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1954-x · Cited by 12
Simili, A., Mazzella, G., Ravaioli, F., Festi, D., Reggiani, M. L. B., Porro, A., Bazzoli, F., & Azzaroli, F. (2019) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-309 · Cited by 12
Alginate Suppresses Liver Fibrosis Through the Inhibition of Nuclear Factor-κB Signaling
Xia, Z., Ding, L., Zheng, J., Xu, Y., Jin, W., Sheng, X., & Wu, J. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s233665 · Cited by 12
The Impact of Hepatitis C Virus Genotypes on Oxidative Stress Markers and Catalase Activity
Đorđević, V., Stanković-Đorđević, D., Kocić, B. D., Dinić, M., Sokolović, D., & Stanković, J. P. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6676057 · Cited by 12
Song, Q., He, X., Hong, Y., Li, J., Chen, M., Wang, M., Liu, Q. F., Yu, J., Yao, J., Liu, L., et al. (2012) · Viral Immunology · doi:10.1089/vim.2011.0053 · Cited by 12
Deconvolution of the cellular origin in hepatocellular carcinoma: Hepatocytes take the center stage
Marquardt, J. U. (2016) · Hepatology · doi:10.1002/hep.28671 · Cited by 13
The role of the canonical nf-κb signaling pathway in the development of acute liver failure
Li, H., Niu, X., Zhang, D., Qu, M., & Yang, K. (2022) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2022.2162999 · Cited by 12
Boran, T., Zengin, Ö. S., Şeker, Z., Akyıldız, A. G., Öztaş, E., & Özhan, G. (2023) · Toxicology Letters · doi:10.1016/j.toxlet.2023.11.005 · Cited by 11
Xie, H., Yang, K., Qin, C., Zhou, X., Liu, J., Nong, J., Luo, J., Wei, Y., Hua, H., Han, C., et al. (2023) · Journal of Cancer · doi:10.7150/jca.89616 · Cited by 11
Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma
Kodama, T., & Takehara, T. (2024) · Seminars in Liver Disease · doi:10.1055/a-2289-2298 · Cited by 15
A role for curcumin in preventing liver fibrosis in animals: a systematic review and meta-analysis
Huang, B.-H., Guo, Z., Lv, B., Zhao, X., Li, Y., & Lv, W. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1396834 · Cited by 14
Inflammation and Immunity in Liver Neoplasms: Implications for Future Therapeutic Strategies
Kim, J., & Seki, E. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0726 · Cited by 11
Allam, E. A. H., Darwish, M., Khalil, N. S. A., El-Baset, S. H. A. A., El–Aal, M. A., Elrawy, A., Ahmed, A. A. N., & Sabra, M. S. (2024) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-024-00795-x · Cited by 11
Oxidative Stress and Inflammation-Related mRNAs Are Elevated in Serum of a Finnish Wet AMD Cohort
Liukkonen, M., Heloterä, H., Siintamo, L., Ghimire, B. R., Mattila, P., Kivinen, N., Kostanek, J., Watała, C. W., Hytti, M., Hyttinen, J. M. T., et al. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.13.30 · Cited by 10
Li, Y., Du, X., & Mao, J. (2025) · International Journal of Oncology · doi:10.3892/ijo.2025.5766 · Cited by 11
Laryngeal and Pharyngeal Squamous Cell Carcinoma After Antireflux Surgery in the 5 Nordic Countries
Yanes, M., Santoni, G., Maret‐Ouda, J., Ness‐Jensen, E., Färkkilä, M. A., Lynge, E., Pukkala, ., Romundstad, P., Tryggvadóttír, L., von Euler‐Chelpin, M., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000004423 · Cited by 11
Wu, Y., He, Q., Shang, M., Yin, Y.-X., Li, Y., Du, X., & Li, X.-R. (2021) · Parasites & Vectors · doi:10.1186/s13071-021-04663-z · Cited by 11
Raj, D., Sharma, V., Upadhyaya, A., Kumar, N., Joshi, R., Acharya, V., Kumar, D., & Patial, V. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114741 · Cited by 11
Fan, W., Liu, X., & Ren, D. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116035 · Cited by 11
Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitis
Chung, K. W., Cho, Y. E., Kim, S.-J., & Hwang, S. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01379-1 · Cited by 11
Jiang, T., Xu, J., Yang, L., Chen, X., & Li, Y. (2022) · Mediators of Inflammation · doi:10.1155/2022/1708030 · Cited by 11
Chen, H., Li, X., Sun, Y.-Y., Du, Y., Wu, S., Wu, Y., Liu, H., Liu, Y., Wang, Y., Zhao, Q., et al. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110436 · Cited by 11
Luo, Q., Ling, Y., Li, Y., Qu, X., Shi, Q.-Q., Zheng, S., Li, Y., Huang, Y., & Zhou, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.964829 · Cited by 11
Rahimi, S., Angaji, S. A., Majd, A., Hatami, B., & Baghaei, K. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175536 · Cited by 11
Compagnoni, C., Capelli, R., Zelli, V., Corrente, A., Vecchiotti, D., Flati, I., Nolfi, M. D. V., Angelucci, A., Alesse, E., Zazzeroni, F., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119239 · Cited by 12
Meng, Y., Ma, Q., Xu, X., Feng, L., Chen, Q., Chen, Y., Li, Z., Liu, C., & Chen, K. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105678 · Cited by 11
Azar, K. A. H. M., Ezhilarasan, D., Harini, K. S., Karthick, M., & Mani, U. (2023) · Cell Biochemistry and Function · doi:10.1002/cbf.3839 · Cited by 11
Wójtowicz, A., Molcan, T., Łukasik, K., Żebrowska, E., Pawlina‐Tyszko, K., Gurgul, A., Szmatoła, T., Bugno‐Poniewierska, M., Ferreira-Dias, G. M., Skarzynski, D. J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-42149-3 · Cited by 11
Jun, H., Liu, S., Knights, A. J., Zhu, K., Ma, Y., Gong, J., Lenhart, A. E., Peng, X., Huang, Y., Ginder, J. P., et al. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002728 · Cited by 11
Liu, C., Wang, Y., Chuang, E. Y.-Y., Tsai, M., Chuang, Y., Lin, C., Liu, C., Hsiao, B., Lin, S., Liu, L.-Y. D., et al. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.21952 · Cited by 11
Animal models of biliary tract injury
Österreicher, C. H., & Trauner, M. A. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835264d9 · Cited by 11
Gaballah, H. H., Zakaria, S. S., & Ismail, S. A. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.16.6911 · Cited by 11
Zhang, C., Zeng, T., Zhao, X., & Xie, K. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.10785 · Cited by 11
Yan, X., Pang, B.-Y., Zhang, Y., Xie, Q., Zhu, Y., Leng, A., Lu, L.-Q., & Chen, H. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.6083 · Cited by 11
Delhove, J. M. K. M., Buckley, S. M. K., Perocheau, D. P. B., Karda, R., Arbuthnot, P. B., Henderson, N. C., Waddington, S. N., & McKay, T. R. (2017) · Scientific Reports · doi:10.1038/srep41874 · Cited by 10
Zhang, T., Hao, H., Zhou, Z., Zeng, T., Zhang, J., & Zhou, X. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106380 · Cited by 11
Rezania, V., Coombe, D., & Tuszyński, J. A. (2020) · Journal of Functional Biomaterials · doi:10.3390/jfb11010013 · Cited by 11
Chu, Y.-W., Chien, C.-H., Sung, M., Chen, C.-W., & Chen, Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234084 · Cited by 11
Wang, R., Wei, L., Dong, Z., Meng, F., Wang, G., Zhou, S.-Y., Lan, X., Liao, Z., & Chen, M. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153548 · Cited by 12
Brochado‐Kith, O., Martínez, I., Berenguer, J., Medrano, L. M., González‐García, J., Jiménez‐Sousa, M. Á., Carrero, A., Hontañón, V., Navarro, J., Guardiola, J. M., et al. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00718-6 · Cited by 11
Association between immunologic markers and cirrhosis in individuals with chronic hepatitis B
Argirion, I., Pfeiffer, R. M., Lam, T. K., OʼBrien, T. R., Yu, K. J., McGlynn, K. A., Petrick, J. L., Pinto, L. A., Chen, C., Lee, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-00455-8 · Cited by 11
Yan, S., Fu, Q., Zhou, Y. K., Zhang, N., Zhou, Q., Wang, X., Yuan, Z., Wang, X., Du, J., Zhang, G., et al. (2013) · Theranostics · doi:10.7150/thno.6997 · Cited by 11
Adak, M., Das, D., Niyogi, S., Challa, N. L., Ray, D., & Chakrabarti, P. (2018) · The FASEB Journal · doi:10.1096/fj.201800190 · Cited by 11
Rahimi, A., Soudi, S., Vakilian, S., Jamshidi‐Adegani, F., Sadeghizadeh, M., & Al‐Hashmi, S. (2022) · Shock · doi:10.1097/shk.0000000000002076 · Cited by 9
Allam, A. M., AbuBakr, H. O., Yassin, A. M., Abdel‐Razek, A. S., Khattab, M. S., Gouda, E. M., & moussa, S. Z. (2023) · Scientific Reports · doi:10.1038/s41598-023-43629-2 · Cited by 10
Scherr, A., Nader, L., Xu, K., Elßner, C., Ridder, D. A., Nichetti, F., Mastel, M., Fritzsche, S., Kelmendi, E., Schmitt, N., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000657 · Cited by 10
Liao, Y., Wei, F., He, Z., He, J., Ai, Y., Guo, C., Zhou, L., Luo, D., Li, C., Wen, Y., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1399882 · Cited by 10
Żurawek, D., Pydyn, N., Major, P., Szade, K., Trzos, K., Kuś, E., Pośpiech, E., Małczak, P., Radkowiak, D., Budzynski, A. Z., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117843 · Cited by 11
The role of cyclic adenosine monophosphate (cAMP) in pathophysiology of fibrosis
Harding, S. L., & Cellek, S. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104368 · Cited by 10
Pamungkas, K. M. N., Dewi, P. I. S. L., Alamsyah, A. Z., Dewi, N. L. P. Y., Dewi, N. N. G. K., Mariadi, I. K., & Sindhughosa, D. A. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i7.106810 · Cited by 11
Hellerbrand, C. (2013) · Gut · doi:10.1136/gutjnl-2013-305908 · Cited by 10
Latief, U., & Ahmad, R. (2020) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000665 · Cited by 11
Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink?
Carroll, H. K., Duffy, A. G., & O’Farrelly, C. (2022) · Seminars in Liver Disease · doi:10.1055/s-0042-1744143 · Cited by 11
Tao, L., Liu, Y., Fan, G., Zhang, H., Zong, Y., & Yang, X. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109933 · Cited by 10
The role of IL-36 and 37 in hepatocellular carcinoma
Cao, J., Liu, J., Wise, S. G., Fan, J., Bao, S., & Zheng, G. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1281121 · Cited by 10
Mondal, A. K., Brock, D. C., Rowan, S., Yang, Z., Rojulpote, K. V., Smith, K., Francisco, S. G., Bejarano, E., English, M. A., Deik, A., et al. (2024) · iScience · doi:10.1016/j.isci.2024.108979 · Cited by 10
El-Zefzafy, W. M., El-Tokhy, H. M., Mohamed, N., & Abu-Zahab, Z. (2015) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2015.021 · Cited by 9
Molecular Mechanisms of Hepatocellular Carcinoma
Alotaibi, H., Atabey, N., Diril, M. K., Erdal, E., & Öztürk, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-34214-6_3 · Cited by 10
Konishi, T., & Lentsch, A. B. (2018) · Hepatology · doi:10.1002/hep.29870 · Cited by 10
Babaei, M., Liu, Y., Wuerzberger‐Davis, S. M., McCaslin, E. Z., DiRusso, C. J., Yeo, A. T., Kagermazova, L., Miyamoto, S., & Gilmore, T. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222588 · Cited by 10
Retracted: HOTAIR regulates lipopolysaccharide‐induced inflammatory response in hepatocytes
Zhang, J., Chen, M., Zhai, Y., & Fu, Y. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29301 · Cited by 10
RetractedShehzad, A., Rehmat, S., Ul-Islam, S., Ahmad, R., Aljafary, M. A., Alrushaid, N., & Al-Suhaimi, E. A. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-2839-3 · Cited by 10
Ye, L., Chen, T., Cao, J., Sun, L., Li, W., & Zhang, C. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5125 · Cited by 10
Nguyen, M. T., Lee, M.-A., Kim, Y., Kook, H., Jeong, D., Jang, S. P., Kwak, T. H., & Park, W. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269735 · Cited by 10
Peach Kernel Extracts Inhibit Lipopolysaccharide‐Induced Activation of HSC‐T6 Hepatic Stellate Cells
Chen, H.-J., Huang, J.-Y., & Ko, C. (2022) · International Journal of Clinical Practice · doi:10.1155/2022/4869973 · Cited by 10
Flores‐Estrada, J., Cano-Martı́nez, A., Vargas-González, Á., Castrejón-Téllez, V., Cornejo‐Garrido, J., Rosas, M., Guarner‐Lans, V., & Rubio-Ruiz, M. E. (2023) · Antioxidants · doi:10.3390/antiox12112013 · Cited by 9
Cheng, M., Zheng, Y., Wu, G., Tan, L., Xu, F., Zhang, Y., Chen, X., & Zhu, K. (2024) · Nutrients · doi:10.3390/nu16010166 · Cited by 9
He, X.-Y., Xiong, X.-J., Liu, M., Liang, J., Liu, F., Xiao, J.-Y., & Wu, L. (2024) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-024-3801-x · Cited by 9
Sun, Y., Shen, H., Fan, C., Wang, C., Fan, Y., Hao, L., Tian, Q., & Hou, H. (2024) · Food & Function · doi:10.1039/d4fo02609h · Cited by 9
SUMO : A new perspective to decipher fibrosis
Li, L., Gao, P., Chen, T., Li, N., Zhang, H., Li, M., Chen, Y., Wei, W., Wang, H., & Sun, W. (2024) · Acta Physiologica · doi:10.1111/apha.14240 · Cited by 9
Wu, Y., Tang, K., Wang, C., Hao, S., Zhou, F., & Guo, Y. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.02.009 · Cited by 10
Chang, W.-Y., Feng, K., Zhou, P., Gong, D.-A., Wang, K., Huang, A.-L., Wang, K., & Tang, N. (2025) · Cancer Science · doi:10.1111/cas.70025 · Cited by 10
Safi, A., Mohammadi, S., Emami, M., Radaei, A., Kalantari‐Hesari, A., Nouri, A., Rahimi‐Madiseh, M., & Ahmadi, R. (2025) · Research in Pharmaceutical Sciences · doi:10.4103/rps.rps_141_24 · Cited by 9
Polymer‐Encapsulated Catalase for Targeted Redox Regulation in Acute Liver Injury
Li, F., Gao, S., Ma, R., Zhang, Y., Li, Y., Wu, D., Han, Z., Li, Q., He, Q., Li, J., et al. (2025) · Small · doi:10.1002/smll.202412349 · Cited by 9
Alcohol-Associated Hepatocarcinogenesis
Xue, Y., Tian, T., Ottallah, M., Mannan, M., Barkin, J., Jin-Smith, B., & Pi, L. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.04.016 · Cited by 10
Cui, H., Ji, H., Zhang, L., Zhang, W., Kang, R., Ni, Y., & Hao, X. (2025) · Phytotherapy Research · doi:10.1002/ptr.70045 · Cited by 9
Abdelghafar, N. S., Hamed, R. I., El-Saied, E. M., Rashad, M. M., Yasin, N. A. E., & Noshy, P. A. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117574 · Cited by 9
Kurosaki, K., & Uesawa, Y. (2022) · The Journal of Toxicological Sciences · doi:10.2131/jts.47.89 · Cited by 10
The Potential of Moringa oleifera to Ameliorate HAART-Induced Pathophysiological Complications
Ndlovu, S. S., Ghazi, T., & Chuturgoon, A. A. (2022) · Cells · doi:10.3390/cells11192981 · Cited by 10
Zhang, X., Li, B., Huo, S., Du, J., Zhang, J., Song, M., Shao, B., & Li, Y. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.167033 · Cited by 10
Ghrelin regulating liver activity and its potential effects on liver fibrosis and Echinococcosis
Zhu, J., Zhou, T., Meng, M., Aimulajiang, K., & Wen, H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1324134 · Cited by 9
You, Y., Chen, S., Deng, H., Xing, X., Tang, B., Wu, Y., & Lei, E. (2024) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2024.102422 · Cited by 9
Lymphotoxin beta‐activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma
Xu, K., Kessler, A., Nichetti, F., Hoffmeister‐Wittmann, P., Scherr, A., Nader, L., Kelmendi, E., Schmitt, N., Schwab, M., Beccaria, M. G., et al. (2024) · Liver International · doi:10.1111/liv.16069 · Cited by 10
Saponara, I., Caruso, E. A., Cofano, M., Nunzio, V. D., Pinto, G., Centonze, M., & Notarnicola, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020512 · Cited by 9
IL-32γ promotes integrin αvβ6 expression through the activation of NF-κB in HSCs
Liu, H., Pan, X., Cao, H., Shu, X., Sun, H., Lu, J., Liang, J., Zhang, K., Zhu, F., Li, G., et al. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4956 · Cited by 9
Abdelaziz, A. O., Abdelhalim, H., Elsharkawy, A. M., Shousha, H. I., Abdelmaksoud, A., Abdellatif, Z., Seif, M. I., Sayed, D. B., Farouk, M. H., Elbaz, T. M., et al. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001343 · Cited by 9
Metadata
- Authors
- Luedde, T., & Schwabe, R. F.
- Affiliations
- Universitätsklinikum Aachen (DE)
- Columbia University Irving Medical Center (US)
- Corresponding author
- Luedde, Tom
- Schwabe, Robert F.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2011-02
- Volume
- 8
- Issue
- 2
- Pages
- 108-118
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- PMC
- PMC3295539
- OpenAlex
- W1976777085
- Cited by
- 1,345
- References
- 137
- Citations by year
- 2026: 97 · 2025: 99 · 2024: 119 · 2023: 109 · 2022: 122 · 2021: 156 · 2020: 120 · 2019: 95 · 2018: 79 · 2017: 76 · 2016: 66 · 2015: 68 · 2014: 51 · 2013: 38 · 2012: 42
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5u54ca126513-03)
- National Institute on Alcohol Abuse and Alcoholism (R01AA020211)
- National Cancer Institute (U54 CA126513.)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK076920)
- National Center for Complementary and Integrative Health (R21AT003878)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Keywords
- NF-κB, liver fibrosis, hepatocellular carcinoma, chronic liver disease, liver cirrhosis, chronic liver injury, liver inflammation, hepatocytes, non-parenchymal liver cells, NF-κB inhibition, hepatocyte viability
- MeSH terms
- Cell Survival, Fibrosis, Carcinoma, Hepatocellular, Homeostasis, Humans, Liver, Liver Neoplasms, NF-kappa B, Hepatocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
